Prevalence of Self-Reported Hypertension and Antihypertensive Medication Use Among Adults — United States, 2017–2021

Hypertension, or high blood pressure, is a major risk factor for heart disease and stroke. It increases with age and is highest among non-Hispanic Black or African American persons, men, persons aged ≥65 years, those of lower socioeconomic status, and those who live in the southern United States. Hypertension affects approximately one half of U.S. adults, and approximately one quarter of those persons have their blood pressure under control. Reducing population-level hypertension prevalence and improving control is a national priority. In 2017, updated guidelines for high blood pressure in adults recommended lowering the blood pressure threshold for diagnosis of hypertension. Analysis of data from the Behavioral Risk Factor Surveillance System found that age-standardized, self-reported diagnosed hypertension was approximately 30% during 2017-2021, with persistent differences by age, sex, race and ethnicity, level of education, and state of residence. During this period, the age-standardized prevalence of antihypertensive medication use among persons with hypertension increased by 3.1 percentage points, from 59.8% to 62.9% (p<0.001). Increases in antihypertensive medication use were observed in most sociodemographic groups and in many states. Assessing current trends in hypertension diagnosis and treatment can help guide the development of policies and implementation of interventions to reduce this important risk factor for cardiovascular disease and can aid in addressing health disparities.

[1]  R. Link-Gelles,et al.  Early Estimate of Nirsevimab Effectiveness for Prevention of Respiratory Syncytial Virus–Associated Hospitalization Among Infants Entering Their First Respiratory Syncytial Virus Season — New Vaccine Surveillance Network, October 2023–February 2024 , 2024, MMWR. Morbidity and mortality weekly report.

[2]  A. Curns,et al.  Respiratory Syncytial Virus-Associated Hospitalizations Among Children <5 Years Old: 2016 to 2020. , 2024, Pediatrics.

[3]  M. LeBourgeois,et al.  Characteristics of Melatonin Use Among US Children and Adolescents. , 2023, JAMA pediatrics.

[4]  Danielle L. Moulia,et al.  Use of the Pfizer Respiratory Syncytial Virus Vaccine During Pregnancy for the Prevention of Respiratory Syncytial Virus–Associated Lower Respiratory Tract Disease in Infants: Recommendations of the Advisory Committee on Immunization Practices — United States, 2023 , 2023, MMWR. Morbidity and mortality weekly report.

[5]  P. Sánchez,et al.  Use of Nirsevimab for the Prevention of Respiratory Syncytial Virus Disease Among Infants and Young Children: Recommendations of the Advisory Committee on Immunization Practices — United States, 2023 , 2023, MMWR. Morbidity and mortality weekly report.

[6]  K. Ferdinand,et al.  Social determinants of health and premature death among adults in the USA from 1999 to 2018: a national cohort study , 2023, The Lancet. Public health.

[7]  M. McMorrow,et al.  Seasonality of Respiratory Syncytial Virus — United States, 2017–2023 , 2023, MMWR. Morbidity and mortality weekly report.

[8]  Rizwan Kalani,et al.  Heart Disease and Stroke Statistics—2023 Update: A Report From the American Heart Association , 2023, Circulation.

[9]  P. Chan,et al.  Data Equity: The Foundation of Out-of-Hospital Cardiac Arrest Quality Improvement. , 2022, Circulation. Cardiovascular quality and outcomes.

[10]  Seema Khosla,et al.  Health advisory: melatonin use in children. , 2022, Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine.

[11]  Karen Hacker,et al.  Social Needs and Social Determinants: The Role of the Centers for Disease Control and Prevention and Public Health , 2022, Public health reports.

[12]  J. Fryzek,et al.  Respiratory Syncytial Virus Is the Leading Cause of United States Infant Hospitalizations, 2009–2019: A Study of the National (Nationwide) Inpatient Sample , 2022, The Journal of infectious diseases.

[13]  J. Pankow,et al.  Racial and Ethnic Differences in All-Cause and Cardiovascular Disease Mortality: The MESA Study , 2022, Circulation.

[14]  M. Neuman,et al.  Pediatric Melatonin Ingestions — United States, 2012–2021 , 2022, MMWR. Morbidity and mortality weekly report.

[15]  Byron C. Jaeger,et al.  Blood Pressure Control Among US Adults, 2009 to 2012 Through 2017 to 2020 , 2022, Hypertension.

[16]  K. Allen,et al.  Association of Burden and Prevalence of Arthritis With Disparities in Social Risk Factors, Findings From 17 US States , 2022, Preventing chronic disease.

[17]  V. Somers,et al.  Trends in Use of Melatonin Supplements Among US Adults, 1999-2018. , 2022, JAMA.

[18]  Rizwan Kalani,et al.  Heart Disease and Stroke Statistics—2022 Update: A Report From the American Heart Association , 2022, Circulation.

[19]  S. Hazen,et al.  Rise in Blood Pressure Observed Among US Adults During the COVID-19 Pandemic , 2021, Circulation.

[20]  W. Aronow,et al.  Temporal Trends in Characteristics and Outcomes Associated With In‐Hospital Cardiac Arrest: A 20‐Year Analysis (1999–2018) , 2021, Journal of the American Heart Association.

[21]  F. Mostashari,et al.  Decreasing primary care use and blood pressure monitoring during COVID-19. , 2021, The American journal of managed care.

[22]  E. Beverly,et al.  Food Insecurity and its Impact on Body Weight, Type 2 Diabetes, Cardiovascular Disease, and Mental Health , 2021, Current Cardiovascular Risk Reports.

[23]  D. Casey,et al.  Controlling High Blood Pressure: An Evidence-Based Blueprint for Change. , 2021, American journal of medical quality : the official journal of the American College of Medical Quality.

[24]  Brady T. West,et al.  Disparities in Diabetes-related Multiple Chronic Conditions and Mortality: The Influence of Race. , 2019, Diabetes research and clinical practice.

[25]  Yuling Hong,et al.  Potential need for expanded pharmacologic treatment and lifestyle modification services under the 2017 ACC/AHA Hypertension Guideline , 2018, Journal of clinical hypertension.

[26]  H. Krumholz,et al.  Impact of 2017 ACC/AHA guidelines on prevalence of hypertension and eligibility for antihypertensive treatment in United States and China: nationally representative cross sectional study , 2018, British Medical Journal.

[27]  Jackson T. Wright,et al.  2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. , 2018, Journal of the American College of Cardiology.

[28]  Jing Fang,et al.  Prevalence of Self-Reported Hypertension and Antihypertensive Medication Use Among Adults Aged ≥18 Years — United States, 2011–2015 , 2018, MMWR. Morbidity and mortality weekly report.

[29]  J. Weinstein,et al.  The Root Causes of Health Inequity , 2017 .

[30]  David R. Williams Racism and Health , 2015 .

[31]  M. Lovegrove,et al.  Trends in Emergency Department Visits for Unsupervised Pediatric Medication Exposures, 2004–2013 , 2015, Pediatrics.

[32]  H. Herkner,et al.  Socioeconomic Risk Factors for Pediatric Out-of-hospital Cardiac Arrest: A Statewide Analysis , 2013, The western journal of emergency medicine.

[33]  Bernhard Resch,et al.  Burden of respiratory syncytial virus infection in young children. , 2012, World journal of clinical pediatrics.

[34]  H. Holzer,et al.  US Census Bureau , 2003 .